SCHEMBL8429100

SCHEMBL8429100

CCCCS(=O)(=O)N(N)C(Cc1ccccc1C(=O)c1cc(NC=NN)cc(C(F)(F)F)c1)C(=O)O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.34
CYP1A2 P05177 3/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2C9 P11712 2/20 0.33
TSHR P16473 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP2D6 P10635 1/20 0.33
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32
APH1B Q8WW43 1/20 0.32
NCSTN Q92542 1/20 0.32
APH1A Q96BI3 1/20 0.32
PSENEN Q9NZ42 1/20 0.32
TRPA1 O75762 1/20 0.32
UBE2M P61081 1/20 0.32
DCUN1D1 Q96GG9 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
NR2E1 Q9Y466 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
TACR1 P25103 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8428874 0.83 BCHE (0.34) BCHETRPA1SMN1; SMN2L3MBTL1TACR1
SCHEMBL8429205 0.83 TACR1 (0.34) BCHESMN1; SMN2L3MBTL1TACR1TAS2R14
SCHEMBL8432545 0.82 BCHE (0.32) BCHESMN1; SMN2TACR1TAS2R14
SCHEMBL8429103 0.71 TRPA1 (0.36) CYP1A2PSEN1PSEN2APH1BNCSTN
SCHEMBL8535813 0.71 TAS2R14 (0.36) BCHECYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL7372541 0.69 ITGB3 (0.45) CYP1A2TRPA1L3MBTL1
SCHEMBL7372544 0.69 ITGB3 (0.45) CYP1A2TRPA1L3MBTL1
SCHEMBL7376890 0.68 MCL1 (0.36) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL7375082 0.67 NNMT (0.34) BCHECYP1A2CYP3A4CYP2C9CYP2D6
SCHEMBL7375079 0.67 NNMT (0.34) BCHECYP1A2CYP3A4CYP2C9CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5952381-A SELECTIVELY INHIBITING OR ANTAGONIZING THE INTEGRINS; ANTITUMOR AGENTS, ANTIARTHRITIC AGENTS, VIRICIDES, MICROBIOCIDES; TREATING OSTEOPOROSIS, SKIN DISORDERS G. D. SEARLE & CO. (US) 1999-09-14 US disclosed